KHTRF
KNIGHT THERAPEUTICS INCstockOTC
EODNov 18, 2026
8.07USD-2.182%(-0.18)1,675
KHTRF News
Knight Therapeutics Inc. Q3 Loss Narrows ·
RTTNews
Knight Therapeutics reports Q3 results ·
Seeking Alpha
Knight Therapeutics Reports Third Quarter 2026 Results ·
GlobeNewswire Inc.
Notice of Knight Therapeutics' Third Quarter 2026 Results Conference Call ·
GlobeNewswire Inc.
Knight Therapeutics Announces Regulatory Approval of NIKTIMVO® in Brazil ·
GlobeNewswire Inc.+1 source
Knight Therapeutics Announces Launch of TAVALISSE® in Brazil ·
GlobeNewswire Inc.+2 sources
Kyowa Kirin, Knight agree Latin American distribution deal for mogamulizumab ·
Pharmaceutical Technology